Transforming growth factor (TGF)-? type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-?1 responses in fibroblasts derived from Peyronie's plaque.

Source:http://linkedlifedata.com/resource/pubmed/id/20233292

Download in:

View as

General Info

PMID
20233292